,
your personalized virtual assistant to find clinical trials. Go head, 
Joan Schiller, MD
UT Southwestern Medical CenterDallas, Texas - 75390 Parkland Memorial HospitalDallas, Texas - 75390 |
- CLINICAL TRIALS 4
- CONDITIONS2
- INTERVENTIONS12
- SINCE2007
Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)
May 2010 - May 2012
A Study of the HSP90 Inhibitor STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
November 2009 - September 2011
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015
Carboplatin Paclitaxel and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer
January 2010 - July 2012
Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Placebo
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Docetaxel
Erlotinib Hydrochloride
Gemcitabine Hydrochloride
Pemetrexed Disodium
Vinorelbine Ditartrate
Sta 9090
Imetelstat
